A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype

N M Albiger, D. Regazzo, B. Rubin, A M Ferrara, S Rizzati, E Taschin, Fabio Ceccato, G. Arnaldi, F Pecori Giraldi, Antonio Stigliano, Lidia Cerquetti, F. Grimaldi, Ernesto De Menis, M. Boscaro, Maurizio Iacobone, Guya Occhi, C. Scaroni

Research output: Contribution to journalArticle

Abstract

ARMC5 mutations have recently been identified as a common genetic cause of primary bilateral macronodular adrenal hyperplasia (PBMAH). We aimed to assess the prevalence of ARMC5 germline mutations and correlate genotype with phenotype in a large cohort of PBMAH patients. A multicenter study was performed, collecting patients from different endocrinology units in Italy. Seventy-one PBMAH patients were screened for small mutations and large rearrangements in the ARMC5 gene: 53 were cortisol-secreting (two with a family history of adrenal hyperplasia) and 18 were non-secreting cases of PBMAH. Non-mutated and mutated patients' clinical phenotypes were compared and related to the type of mutation. A likely causative germline ARMC5 mutation was only identified in cortisol-secreting PBMAH patients (one with a family history of adrenal hyperplasia and ten apparently sporadic cases). Screening in eight first-degree relatives of three index cases revealed four carriers of an ARMC5 mutation. Evidence of a second hit at somatic level was identified in five nodules. Mutated patients had higher cortisol levels (p = 0.062), and more severe hypertension and diabetes (p < 0.05). Adrenal glands were significantly larger, with a multinodular phenotype, in the mutant group (p < 0.01). No correlation emerged between type of mutation and clinical parameters. ARMC5 mutations are frequent in cortisol-secreting PBMAH and seem to be associated with a particular pattern of the adrenal masses. Their identification may have implications for the clinical care of PBMAH cases and their relatives.

Original languageEnglish
Pages (from-to)959-968
Number of pages10
JournalEndocrine
Volume55
Issue number3
Early online dateApr 19 2016
DOIs
Publication statusPublished - Mar 2017

Fingerprint

Hyperplasia
Phenotype
Mutation
Hydrocortisone
Germ-Line Mutation
Endocrinology
Adrenal Glands
Italy
Multicenter Studies
Primary Health Care
Genotype
Hypertension
Genes

Keywords

  • Journal Article

Cite this

A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia : from genetic characterization to clinical phenotype. / Albiger, N M; Regazzo, D.; Rubin, B.; Ferrara, A M; Rizzati, S; Taschin, E; Ceccato, Fabio; Arnaldi, G.; Pecori Giraldi, F; Stigliano, Antonio; Cerquetti, Lidia; Grimaldi, F.; De Menis, Ernesto; Boscaro, M.; Iacobone, Maurizio; Occhi, Guya; Scaroni, C.

In: Endocrine, Vol. 55, No. 3, 03.2017, p. 959-968.

Research output: Contribution to journalArticle

Albiger, NM, Regazzo, D, Rubin, B, Ferrara, AM, Rizzati, S, Taschin, E, Ceccato, F, Arnaldi, G, Pecori Giraldi, F, Stigliano, A, Cerquetti, L, Grimaldi, F, De Menis, E, Boscaro, M, Iacobone, M, Occhi, G & Scaroni, C 2017, 'A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype', Endocrine, vol. 55, no. 3, pp. 959-968. https://doi.org/10.1007/s12020-016-0956-z
Albiger, N M ; Regazzo, D. ; Rubin, B. ; Ferrara, A M ; Rizzati, S ; Taschin, E ; Ceccato, Fabio ; Arnaldi, G. ; Pecori Giraldi, F ; Stigliano, Antonio ; Cerquetti, Lidia ; Grimaldi, F. ; De Menis, Ernesto ; Boscaro, M. ; Iacobone, Maurizio ; Occhi, Guya ; Scaroni, C. / A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia : from genetic characterization to clinical phenotype. In: Endocrine. 2017 ; Vol. 55, No. 3. pp. 959-968.
@article{b136172acf004245a1973de0b35d2629,
title = "A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype",
abstract = "ARMC5 mutations have recently been identified as a common genetic cause of primary bilateral macronodular adrenal hyperplasia (PBMAH). We aimed to assess the prevalence of ARMC5 germline mutations and correlate genotype with phenotype in a large cohort of PBMAH patients. A multicenter study was performed, collecting patients from different endocrinology units in Italy. Seventy-one PBMAH patients were screened for small mutations and large rearrangements in the ARMC5 gene: 53 were cortisol-secreting (two with a family history of adrenal hyperplasia) and 18 were non-secreting cases of PBMAH. Non-mutated and mutated patients' clinical phenotypes were compared and related to the type of mutation. A likely causative germline ARMC5 mutation was only identified in cortisol-secreting PBMAH patients (one with a family history of adrenal hyperplasia and ten apparently sporadic cases). Screening in eight first-degree relatives of three index cases revealed four carriers of an ARMC5 mutation. Evidence of a second hit at somatic level was identified in five nodules. Mutated patients had higher cortisol levels (p = 0.062), and more severe hypertension and diabetes (p < 0.05). Adrenal glands were significantly larger, with a multinodular phenotype, in the mutant group (p < 0.01). No correlation emerged between type of mutation and clinical parameters. ARMC5 mutations are frequent in cortisol-secreting PBMAH and seem to be associated with a particular pattern of the adrenal masses. Their identification may have implications for the clinical care of PBMAH cases and their relatives.",
keywords = "Journal Article",
author = "Albiger, {N M} and D. Regazzo and B. Rubin and Ferrara, {A M} and S Rizzati and E Taschin and Fabio Ceccato and G. Arnaldi and {Pecori Giraldi}, F and Antonio Stigliano and Lidia Cerquetti and F. Grimaldi and {De Menis}, Ernesto and M. Boscaro and Maurizio Iacobone and Guya Occhi and C. Scaroni",
year = "2017",
month = "3",
doi = "10.1007/s12020-016-0956-z",
language = "English",
volume = "55",
pages = "959--968",
journal = "Endocrine",
issn = "1355-008X",
publisher = "Humana Press Inc.",
number = "3",

}

TY - JOUR

T1 - A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia

T2 - from genetic characterization to clinical phenotype

AU - Albiger, N M

AU - Regazzo, D.

AU - Rubin, B.

AU - Ferrara, A M

AU - Rizzati, S

AU - Taschin, E

AU - Ceccato, Fabio

AU - Arnaldi, G.

AU - Pecori Giraldi, F

AU - Stigliano, Antonio

AU - Cerquetti, Lidia

AU - Grimaldi, F.

AU - De Menis, Ernesto

AU - Boscaro, M.

AU - Iacobone, Maurizio

AU - Occhi, Guya

AU - Scaroni, C.

PY - 2017/3

Y1 - 2017/3

N2 - ARMC5 mutations have recently been identified as a common genetic cause of primary bilateral macronodular adrenal hyperplasia (PBMAH). We aimed to assess the prevalence of ARMC5 germline mutations and correlate genotype with phenotype in a large cohort of PBMAH patients. A multicenter study was performed, collecting patients from different endocrinology units in Italy. Seventy-one PBMAH patients were screened for small mutations and large rearrangements in the ARMC5 gene: 53 were cortisol-secreting (two with a family history of adrenal hyperplasia) and 18 were non-secreting cases of PBMAH. Non-mutated and mutated patients' clinical phenotypes were compared and related to the type of mutation. A likely causative germline ARMC5 mutation was only identified in cortisol-secreting PBMAH patients (one with a family history of adrenal hyperplasia and ten apparently sporadic cases). Screening in eight first-degree relatives of three index cases revealed four carriers of an ARMC5 mutation. Evidence of a second hit at somatic level was identified in five nodules. Mutated patients had higher cortisol levels (p = 0.062), and more severe hypertension and diabetes (p < 0.05). Adrenal glands were significantly larger, with a multinodular phenotype, in the mutant group (p < 0.01). No correlation emerged between type of mutation and clinical parameters. ARMC5 mutations are frequent in cortisol-secreting PBMAH and seem to be associated with a particular pattern of the adrenal masses. Their identification may have implications for the clinical care of PBMAH cases and their relatives.

AB - ARMC5 mutations have recently been identified as a common genetic cause of primary bilateral macronodular adrenal hyperplasia (PBMAH). We aimed to assess the prevalence of ARMC5 germline mutations and correlate genotype with phenotype in a large cohort of PBMAH patients. A multicenter study was performed, collecting patients from different endocrinology units in Italy. Seventy-one PBMAH patients were screened for small mutations and large rearrangements in the ARMC5 gene: 53 were cortisol-secreting (two with a family history of adrenal hyperplasia) and 18 were non-secreting cases of PBMAH. Non-mutated and mutated patients' clinical phenotypes were compared and related to the type of mutation. A likely causative germline ARMC5 mutation was only identified in cortisol-secreting PBMAH patients (one with a family history of adrenal hyperplasia and ten apparently sporadic cases). Screening in eight first-degree relatives of three index cases revealed four carriers of an ARMC5 mutation. Evidence of a second hit at somatic level was identified in five nodules. Mutated patients had higher cortisol levels (p = 0.062), and more severe hypertension and diabetes (p < 0.05). Adrenal glands were significantly larger, with a multinodular phenotype, in the mutant group (p < 0.01). No correlation emerged between type of mutation and clinical parameters. ARMC5 mutations are frequent in cortisol-secreting PBMAH and seem to be associated with a particular pattern of the adrenal masses. Their identification may have implications for the clinical care of PBMAH cases and their relatives.

KW - Journal Article

U2 - 10.1007/s12020-016-0956-z

DO - 10.1007/s12020-016-0956-z

M3 - Article

C2 - 27094308

VL - 55

SP - 959

EP - 968

JO - Endocrine

JF - Endocrine

SN - 1355-008X

IS - 3

ER -